EQS-News: SCHOTT Pharma AG & Co. KGaA / Key word (s): Quarterly / Interim Statement/Quarter Results SCHOTT Pharma records good start into fiscal year and confirms full year outlook 13.02.2025 / ...

"We have the same outcome goals, the same desires," advocate Mindy Vincent said of GOP Rep. Tyler Clancy. "Our hearts are in ...

Eden is providing access to a new way for individuals to explore GLP-1 therapy: a compounded semaglutide gummy, available ...

The SCIg market is growing rapidly, with KORU Medical Systems outperforming competitors by capturing market share. Read why I ...

Event of the Heart, which is the primary fundraiser for MCAVHN Care and Prevention Network takes place on Feb. 15 at the ...

Members of our Community Editorial Board, a group of community residents who are engaged with and passionate about local ...

Provo, this week presented the second of two comprehensive homelessness bills that he is spearheading this legislative ...

Microlenses applied to eyeglasses can help reduce growth-related worsening of nearsightedness (myopia), preventing potential ...

All three were hooked up to machines that provided a readout of their vital signs, and all three were prepared to have a ...

You’ll need to use two syringes, one right after the other, for this dose. After that, you’ll have a maintenance dosage of 120 mg every month. Yes, Emgality is usually used as a long-term ...

A key trend in the pharmaceutical industry is currently long-acting drug delivery. Here, instead of taking tablets daily, a patient receives an injection or implant that contains weeks or months of ...